Skip to main content
SpringerLink
Log in

Design, synthesis, and neuroprotective effects of a dimeric dipeptide mimetic of the third loop of the nerve growth factor

  • Published:
Russian Journal of Bioorganic Chemistry Aims and scope Submit manuscript

Abstract

Previously, we prepared dimeric dipeptide mimetics of the first and the fourth loops of the nerve growth factor (NGF): hexamethylenediamides of bis(N-aminocaproyl-glycyl-L-lysine) (GK-6) and bis(N-monosuccinyl-L-glutamyl-L-lysine) (GK-2). Both mimetics activated TrkA-receptors, but induced different postreceptor signal pathways. GK-2 selectively activated PI3K/AKT, whereas GK-6 activated both PI3K/AKT and MAPK/ERK. Both mimetics exhibited a neuroprotective activity. In this study, we continued the investigation of a contribution of separate loop-like structures in the NGF functions and created and studied dimeric dipeptide mimetics based on a beta-turn of the NGF third loop: hexamethylenediamides of bis(N-gamma-hydroxybutyryl-L-lysyl-L-histidine) (GTS-115) and bis(N-acetyl-L-lysyl-L-histidine) (GTS-113). GTS-115 was shown to exhibit the neuroprotective activity in the concentration range from 10–5 to 10–7 М towards the HT-22 cell culture under the conditions of oxidative stress. The acetyl-containing GTS-113 mimetic proved to be inactive. GTS-115 (1 mg/kg/day intraperitoneally, for 7 days, the administration was started 4 h after the operation) exhibited the neuroprotective properties and decreased the infarction volume by 25% on the model of a stroke that was induced by a transient occlusion of the medial cerebral artery of rats. The action mechanism of GTS-115 was studied by Western-blot analysis and this mimetic in a concentration of 10–6 М was shown to activate the TrkA-receptor and both MAPK/ERK and PI3K/AKT basic postreceptor signal pathways. The inhibitory analysis revealed different contributions of these pathways into the GTS-115 neuroprotective effect. The LY294002 selective inhibitor of PI3K completely blocked the neuroprotective effect of GTS-115 in vitro, whereas the PD98059 specific inhibitor of MEK1 and MEK2 decreased this effect only by 10–15%. GTS-115 peptide stimulated a differentiation of the PC12 cells and caused a hyperalgesia in rats. These facts were in a good agreement with the literature data on the participation of the MAP-kinase pathway in these effects. Thus, the third NGF loop and the neighboring first NGF loop activated the postreceptor pathways in a similar way and exhibited the similar activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BuONO:

n-butyl nitrite

DCС:

1,3-dicyclohexylcarbodiimide

DCU:

1,3-dicyclohexylurea

DIEA:

N,N-diisopropylethylamine

DMAPA:

3-(dimethylamino)propylamine

GHB:

gamma–hydroxybutyric acid

MAPK/ERK:

the mitogen-activated proteinkinase pathway

NGF:

the nerve growth factor

PI3K/AKT:

phosphatidyl inositol-3-kinase pathway

TEA:

triethylamine

TFA:

trifluoroacetic acid

References

  1. Levi-Montalcini, R., Science, 1987, vol. 237, pp. 1154–1162.

    Article  CAS  PubMed  Google Scholar 

  2. Aloe, L., Rocco, M.L., Bianchi, P., and Manni, L., J. Transl. Med., 2012, vol. 10, no. 11, pp. 239–252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kaplan, D.R. and Miller, F.D., Curr. Opin. Neurobiol., 2000, vol. 10, no. 3, pp. 381–391.

    Article  CAS  PubMed  Google Scholar 

  4. Obata, K. and Noguchi, K., Life Sci., 2004, vol. 74, no. 21, pp. 2643–5263.

    Article  CAS  PubMed  Google Scholar 

  5. Gudasheva, T.A., Antipova, T.A., and Seredenin, S.B., Dokl. Biochem. Biophys., 2010, vol. 434, pp. 262–265.

    Article  CAS  PubMed  Google Scholar 

  6. Seredenin, S.B. and Gudasheva, T.A., Dipeptide mimetics of neurotrophins NGF and BDNF, RF Patent no. 2410392, Byul. Izobret., 2011, no. 3.

    Google Scholar 

  7. Gudasheva, T.A., Povarnina, P.Yu., Antipova, T.A., and Seredenin, S.B., Neurosci. Med., 2014, vol. 5, no. 2, pp. 101–108.

    Article  CAS  Google Scholar 

  8. Seredenin, S.B. and Gudasheva, T.A., Zh. Nevrol. Psikhiatr. im. S.S. Korsakova, 2015, vol. 115, no. 6, pp. 63–70.

    Article  CAS  PubMed  Google Scholar 

  9. Gudasheva, T.A., Povarnina, P.Y., Antipova, T.A., Firsova, Y.N., Konstantinopolsky, M.A., and Seredenin, S.B., J. Biomed. Sci., 2015, vol. 22, p. 106.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Jackson, G.R., Werrbach-Perez, K., Ezell, E.L., Post, J.F., and Perez-Polo, J.R., Brain Res., 1992, vol. 592, nos. 1–2, pp. 239–248.

    Article  CAS  PubMed  Google Scholar 

  11. Virdee, K. and Tolkovsky, A.M., J. Neurochem., 1996, vol. 67, no. 5, pp. 1801–1805.

    Article  CAS  PubMed  Google Scholar 

  12. Chang, J.H., Mellon, E., Schanen, N.C., and Twiss, J.L., J. Biol. Chem., 2003, vol. 278, no. 44, pp. 42877–42885.

    Article  CAS  PubMed  Google Scholar 

  13. Longa, E.Z., Weinstein, P.R., Carlson, S., and Cummins, R., Stroke, 1989, vol. 20, no. 1, pp. 84–91.

    Article  CAS  PubMed  Google Scholar 

  14. De Ryck, M., Van Reempts, J., Borgers, M., Wauquier, A., and Janssen, P.A., Stroke, 1989, vol. 20, no. 10, pp. 1383–1390.

    Article  PubMed  Google Scholar 

  15. Jolkkonen, J., Puurunen, K., Rantakomi, S., Harkonen, A., Haapalinna, A., and Sivenius, J., Eur. J. Pharmacol., 2000, vol. 400, nos. 2–3, pp. 211–219.

    Article  CAS  PubMed  Google Scholar 

  16. Hathway, G.J. and Fitzgerald, M., J. Pain, 2006, vol. 7, pp. 57–61.

    Article  CAS  PubMed  Google Scholar 

  17. Taglialatela, G., Foreman, P.J., and Perez-Polo, J.R., Int. J. Dev. Neurosci., 1997, vol. 15, no. 6, pp. 703–710.

    Article  CAS  PubMed  Google Scholar 

  18. Khan, S.A., Chatterjee, S.S., and Kumar, V., Life Sci., 2016, vol. 148, pp. 53–62.

    Article  CAS  PubMed  Google Scholar 

  19. Tarasyuk, A.V., Pomogaibo, S.V., Kurilov, D.V., and Gudasheva, T.A., Pharm. Chem. J., 2013, no. 1, pp. 20–27.

    Article  Google Scholar 

  20. Jaouadi, M., Martinez, J., and Castro, B., Org. Chem., 1987, vol. 52, pp. 2364–2367.

    Article  CAS  Google Scholar 

  21. Ueda, Y., Walsh, E., Nakanishi, H., and Yoshida, K., Neurosci. Lett., 1994, vol. 165, nos 1–2, pp. 203–207.

    Article  CAS  PubMed  Google Scholar 

  22. Alam, A., Anal. Biochem., 1992, vol. 203, no. 1, pp. 121–126.

    Article  CAS  PubMed  Google Scholar 

  23. Towbin, H., Staehelin, T., and Gordon, J., Proc. Natl. Acad. Sci. U. S. A., 1979, vol. 76, no. 9, pp. 4350–4354.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kukhtina, V.V., Tsetlin, V.I., Utkin, Y.N., Inozemtseva, L.S., and Grivennikov, I.A., J. Nat. Toxins, 2001, vol. 10, no. 1, pp. 9–16.

    CAS  PubMed  Google Scholar 

  25. Brown, R.F., Hui, K.Y., Matter, W.F., and Vlahos, C.J., J. Biol. Chem., 1994, vol. 269, no. 7, pp. 5241–5248.

    PubMed  Google Scholar 

  26. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R., J. Biol. Chem., 1995, vol. 270, no. 46, pp. 27489–27494.

    Article  CAS  PubMed  Google Scholar 

  27. Siren, A.L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., et al., Proc. Natl. Acad. Sci. U. S. A., 2001, vol. 98, no. 7, pp. 4044–4049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Hathway, G.J. and Fitzgerald, M., J. Pain, 2006, vol. 7, no. 1, pp. 57–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zakusov Research Institute of Pharmacology, Moscow, 125315, Russia

    T. A. Gudasheva, A. V. Tarasiuk, N. M. Sazonova, S. V. Pomogaibo, A. N. Shumskiy, I. O. Logvinov, S. V. Nikolaev, P. Yu. Povarnina, M. A. Konstantinopolsky, T. A. Antipova & S. B. Seredenin

Authors
  1. T. A. Gudasheva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. V. Tarasiuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. M. Sazonova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. V. Pomogaibo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. N. Shumskiy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. O. Logvinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. V. Nikolaev
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Yu. Povarnina
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. A. Konstantinopolsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. T. A. Antipova
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S. B. Seredenin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. A. Gudasheva.

Additional information

Original Russian Text © T.A. Gudasheva, A.V. Tarasiuk, N.M. Sazonova, S.V. Pomogaibo, A.N. Shumskiy, I.O. Logvinov, S.V. Nikolaev, P.Yu. Povarnina, M.A. Konstantinopolsky, T.A. Antipova, S.B. Seredenin, 2017, published in Bioorganicheskaya Khimiya, 2017, Vol. 43, No. 3, pp. 236–249.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gudasheva, T.A., Tarasiuk, A.V., Sazonova, N.M. et al. Design, synthesis, and neuroprotective effects of a dimeric dipeptide mimetic of the third loop of the nerve growth factor. Russ J Bioorg Chem 43, 235–247 (2017). https://doi.org/10.1134/S1068162017030050

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162017030050

Keywords

Search

Navigation